The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
PLGA-based nanoparticles: An overview of biomedical applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
RetractedTumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Bone: Formation by Autoinduction
Urist, M. R. (1965) · Science · doi:10.1126/science.150.3698.893 · Cited by 5,546
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Self-citationNanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Kawai, T., & Akira, S. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.004 · Cited by 1,404
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G., Moro, E., Heywood, P., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20737 · Cited by 983
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 824
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Cho, T.-J., Gerstenfeld, L. C., & Einhorn, T. A. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.513 · Cited by 739
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
van de Weert, M., Hennink, W. E., & Jiskoot, W. (2000) · Pharmaceutical Research · doi:10.1023/a:1026498209874 · Cited by 708
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M. (2000) · Circulation · doi:10.1161/01.cir.102.8.898 · Cited by 697
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
McKay, W. F., Peckham, S. M., & Badura, J. M. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0418-6 · Cited by 616
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Self-citationStabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Pathogen recognition in the innate immune response
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical Journal · doi:10.1042/bj20090272 · Cited by 590
Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles
Yue, Z.-G., Wei, W., Lv, P.-P., Yue, H., Wang, L.-Y., Su, Z.-G., & Ma, G.-H. (2011) · Biomacromolecules · doi:10.1021/bm101482r · Cited by 567
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Current status of prosthetic bypass grafts: A review
Kannan, R. Y., Salacinski, H. J., Butler, P. E., Hamilton, G., & Seifalian, A. M. (2005) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.30247 · Cited by 527
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research · doi:10.1023/a:1011032328064 · Cited by 507
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Slevin, J. T., Gerhardt, G. A., Smith, C. D., Gash, D. M., Kryscio, R., & Young, B. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.2.0216 · Cited by 475
Role and Therapeutic Potential of VEGF in the Nervous System
Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., & Carmeliet, P. (2009) · Physiological Reviews · doi:10.1152/physrev.00031.2008 · Cited by 448
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
Kelly, C., Jefferies, C., & Cryan, S.-A. (2011) · Journal of Drug Delivery · doi:10.1155/2011/727241 · Cited by 425
Biodegradation of PLA/GA polymers: increasing complexity
Vert, M., Mauduit, J., & Li, S. (1994) · Biomaterials · doi:10.1016/0142-9612(94)90271-2 · Cited by 425
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
Influence of the mannose receptor in host immune responses
Gazi, U., & Martinez-Pomares, L. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.004 · Cited by 419
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
Lübbe, A. S., Bergemann, C., Huhnt, W., Fricke, T., Riess, H. B., Brock, J., & Huhn, D. (1996) · PubMed · Cited by 397
Price, R. J., Skyba, D. M., Kaul, S., & Skalak, T. C. (1998) · Circulation · doi:10.1161/01.cir.98.13.1264 · Cited by 393
Cui, F., Shi, K., Zhang, L., Tao, A., & Kawashima, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.013 · Cited by 391
Yamamoto, H., Kuno, Y., Sugimoto, S., Takeuchi, H., & Kawashima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.010 · Cited by 389
Patel, N. K., Bunnage, M., Plaha, P., Svendsen, C. N., Heywood, P., & Gill, S. S. (2005) · Annals of Neurology · doi:10.1002/ana.20374 · Cited by 386
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Guinedi, A. S., Mortada, N. D., Mansour, S., & Hathout, R. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.023 · Cited by 355
Hu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
Self-citationRangel, L. B. A., Agarwal, R., D’Souza, T., Pizer, E. S., Alò, P., Lancaster, W. D., Grégoire, L., Schwartz, D. R., Cho, K. R., & Morin, P. J. (2003) · PubMed · Cited by 335
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Yilgor, P., Tuzlakoglu, K., Reis, R. L., Hasirci, N., & Hasirci, V. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.024 · Cited by 323
Bessa, P. C., Casal, M., & Reis, R. L. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.63 · Cited by 322
Patil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281
Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion
White, A. P., Vaccaro, A. R., Hall, J. A., Whang, P. G., Friel, B. C., & McKee, M. D. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0422-x · Cited by 270
Vasir, J. K., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.020 · Cited by 268
Endocytosis mechanisms and the cell biology of antigen presentation
Burgdorf, S., & Kurts, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.12.002 · Cited by 266
Reddy, M. K., & Labhasetwar, V. (2009) · The FASEB Journal · doi:10.1096/fj.08-116947 · Cited by 264
Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.062 · Cited by 261
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Toll‐like receptors – sentries in the B‐cell response
Bekeredjian‐Ding, I., & Jego, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03173.x · Cited by 243
Thomas, C., Rawat, A., Hope-Weeks, L., & Ahsan, F. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100255c · Cited by 241
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery
Zhang, Z., Huey Lee, S., & Feng, S.-S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.018 · Cited by 238
Tosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234
Cun, D., Jensen, D. K., Maltesen, M. J., Bunker, M., Whiteside, P., Scurr, D., Foged, C., & Nielsen, H. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.008 · Cited by 233
Jain, A. K., Swarnakar, N. K., Godugu, C., Singh, R. P., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.037 · Cited by 232
Gene delivery from a DNA controlled-release stent in porcine coronary arteries
Klugherz, B. D., Jones, P. L., Cui, X., Chen, W., Meneveau, N. F., DeFelice, S., Connolly, J., Wilensky, R. L., & Levy, R. J. (2000) · Nature Biotechnology · doi:10.1038/81176 · Cited by 231
Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles
Dillen, K., Vandervoort, J., Van den Mooter, G., & Ludwig, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.041 · Cited by 230
Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., Reinhold, B., Keskin, D. B., Reinherz, E. L., & Sasada, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.067 · Cited by 228
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
Kohane, D. S., Tse, J. Y., Yeo, Y., Padera, R., Shubina, M., & Langer, R. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30654 · Cited by 217
Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 208
Plasticity in programming of effector and memory CD8+ T‐cell formation
Arens, R., & Schoenberger, S. P. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00899.x · Cited by 207
Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells
Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H., Hirashima, N., & Kawashima, Y. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.023 · Cited by 206
Slütter, B., Bal, S., Keijzer, C., Mallants, R., Hagenaars, N., Que, I., Kaijzel, E., van Eden, W., Augustijns, P., Löwik, C., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.121 · Cited by 201
Derakhshandeh, K., Erfan, M., & Dadashzadeh, S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.004 · Cited by 200
Ulbrich, W., & Lamprecht, A. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0285.focus · Cited by 197
Siglecs as targets for therapy in immune-cell-mediated disease
O’Reilly, M. K., & Paulson, J. C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.005 · Cited by 187
Lamprecht, A., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088146 · Cited by 187
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
Chittasupho, C., Xie, S.-X., Baoum, A., Yakovleva, T., Siahaan, T. J., & Berkland, C. J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.008 · Cited by 181
Horisawa, E., Kubota, K., Tuboi, I., Sato, K., Yamamoto, H., Takeuchi, H., & Kawashima, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1014260513728 · Cited by 169
Sarkar, S., Lee, G. Y., Wong, J. Y., & Desai, T. A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.038 · Cited by 169
Basic and Clinical Immunology of Siglecs
Von Gunten, S., & Bochner, B. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.011 · Cited by 167
Model of transient drug diffusion across cornea
Zhang, W., Prausnitz, M. R., & Edwards, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.001 · Cited by 166
Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth
Golub, J. S., Kim, Y.-T., Duvall, C. L., Bellamkonda, R. V., Gupta, D., Lin, A. S., Weiss, D., Robert Taylor, W., & Guldberg, R. E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00199.2009 · Cited by 164
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application
Agnihotri, S. M., & Vavia, P. R. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.003 · Cited by 164
Wohlfart, S., Khalansky, A. S., Gelperina, S., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors
Luo, G., Yu, X., Jin, C., Yang, F., Fu, D., Long, J., Xu, J., Zhan, C., & Lu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.014 · Cited by 161
Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair
Cao, L. (2003) · Brain · doi:10.1093/brain/awh072 · Cited by 161
Araújo, J., Vega, E., Lopes, C. M., Egea, M. A., García, M. L., & Souto, E. B. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.03.028 · Cited by 160
“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells
Elamanchili, P., Lutsiak, C. M. E., Hamdy, S. I., Diwan, M., & Samuel, J. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802cf3e3 · Cited by 160
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Self-citationTopical Nonsteroidal Anti-Inflammatory Therapy in Ophthalmology
Schalnus, R., & Schalnus, R. (2003) · Ophthalmologica · doi:10.1159/000068563 · Cited by 157
PEGylation strategies for active targeting of PLA/PLGA nanoparticles
Betancourt, T., Byrne, J. D., Sunaryo, N., Crowder, S. W., Kadapakkam, M., Patel, S., Casciato, S. L., & Brannon‐Peppas, L. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32247 · Cited by 155
Sequential BMP‐2/BMP‐7 delivery from polyester nanocapsules
Yilgor, P., Hasırcı, N., & Hasırcı, V. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32520 · Cited by 153
Higaki, M., Ishihara, T., Izumo, N., Takatsu, M., & Mizushima, Y. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.030759 · Cited by 153
Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease
Garbayo, E., Montero-Menei, C. N., Ansorena, E., Lanciego, J. L., Aymerich, M. S., & Blanco-Prieto, M. J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.010 · Cited by 150
Self-citationCritical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression
Prabha, S., & Labhasetwar, V. D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016250.56402.99 · Cited by 150
Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin
Cartiera, M. S., Ferreira, E. C., Caputo, C. R., Egan, M. E., Caplan, M. J., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900138a · Cited by 149
Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress
Reddy, M. K., Wu, L., Kou, W., Ghorpade, A., & Labhasetwar, V. D. (2008) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-008-8232-1 · Cited by 146
3D systems delivering VEGF to promote angiogenesis for tissue engineering
Rieux, A. D., Učakar, B., Mupendwa, B. P. K., Colau, D., Féron, O., Carmeliet, P., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.028 · Cited by 146
PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions
Vega, E., Gamisans, F., García, M. L., Chauvet, A., Lacoulonche, F., & Egea, M. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21383 · Cited by 144
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles
Toti, U. S., Guru, B. R., Hali, M., McPharlin, C. M., Wykes, S. M., Panyam, J., & Whittum-Hudson, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.038 · Cited by 143
The ABC of clinical and experimental adjuvants—A brief overview
Brunner, R., Jensen‐Jarolim, E., & Pali‐Schöll, I. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.005 · Cited by 140
Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.002 · Cited by 139
Horisawa, E., Hirota, T., Kawazoe, S., Yamada, J., Yamamoto, H., Takeuchi, H., & Kawashimà, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1015123024113 · Cited by 138
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery
Cui, F., Tao, A., Cun, D., et al. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20750 · Cited by 136
Kim, I., Lee, S., Park, Y., Lee, Y., Shin, S.-C., Lee, K. C., & Oh, I.-J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.04.017 · Cited by 128
Vij, N., Min, T., Marasigan, R. E. R., Belcher, C. N., Mazur, S., Ding, H. Y., Yong, K., & Roy, I. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-22 · Cited by 128
de Jong, S. D., Chikh, G., Sekirov, L., Raney, S. G., Semple, S. C., Klimuk, S. K., Yuan, N., Hope, M., Cullis, P. R., & Tam, Y. K. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0276-x · Cited by 127
Tosi, G., Vergoni, A. V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., Costantino, L., Forni, F., & Vandelli, M. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.008 · Cited by 124
Wang, Y., Ng, Y. W., Chen, Y., Shuter, B., Yi, J., Ding, J., Wang, S., & Feng, S. (2008) · Advanced Functional Materials · doi:10.1002/adfm.200700456 · Cited by 123
Prasad, S., Cody, V., Saucier-Sawyer, J. K., Saltzman, W. M., Sasaki, C. T., Edelson, R. L., Birchall, M., & Hanlon, D. J. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.07.002 · Cited by 122
Nanoparticles in inflammatory bowel disease: Particle targeting versus pH-sensitive delivery
Meißner, Y., Pellequer, Y., & Lamprecht, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.032 · Cited by 120
Diwan, M., Elamanchili, P., Lane, H. C., Gainer, A. L., & Samuel, J. (2003) · Journal of drug targeting · doi:10.1080/10611860410001670026 · Cited by 119
The mechanisms of cancer immunoescape and development of overcoming strategies
Yaguchi, T., Sumimoto, H., Kudo‐Saito, C., Tsukamoto, N., Ueda, R., Iwata‐Kajihara, T., Nishio, H., Kawamura, N., & Kawakami, Y. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0799-6 · Cited by 118
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Dendritic Cells—A Conductor of T Cell Differentiation—
Kadowaki, N. (2007) · Allergology International · doi:10.2332/allergolint.r-07-146 · Cited by 117
Targeted delivery of therapeutics to endothelium
Simone, E. A., Ding, B., & Muzykantov, V. R. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0676-7 · Cited by 116
Wang, Y., Wu, Y.-T., Huang, H.-Y., Lin, H.-I., Lo, L., Tzeng, S., & Yang, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.050 · Cited by 114
Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
Hamdy, S. I., Haddadi, A., Shayeganpour, A., Samuel, J., & Lavasanifar, A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0459-9 · Cited by 113
Improved therapeutic effect of folate-decorated PLGA–PEG nanoparticles for endometrial carcinoma
Liang, C., Yang, Y., Ling, Y., Huang, Y., Li, T. X., & Li, X. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.016 · Cited by 111
Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels
Liu, J., Zhang, S. M., Chen, P., Cheng, L., Zhou, W., Tang, W. X., Chen, Z. W., & Ke, C. M. (2007) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-007-3010-0 · Cited by 109
Zhao, L., & Feng, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22113 · Cited by 109
Modulation of immune responses through direct activation of Toll-like receptors to T cells
GuoHong, L. I. U., Zhang, L., & Zhao, Y. L. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04091.x · Cited by 107
Tian, J., & Yu, J. (2011) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2010.09.016 · Cited by 107
Cheng, H., Wu, J., & Tzeng, S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10303 · Cited by 104
Jollivet, C., Aubert‐Pouëssel, A., Clavreul, A., Venier‐Julienne, M., Remy, S., Montero‐Menei, C. N., Benoît, J., & Meneï, P. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00601-x · Cited by 103
Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
Jandus, C., Simon, H., & von Gunten, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.018 · Cited by 103
Wang, Z., Chui, W., & Ho, P. C. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9837-y · Cited by 100
Chen, H., Gao, J., Lu, Y., Kou, G., Zhang, H., Fan, L., Sun, Z., Guo, Y., & Zhong, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.010 · Cited by 97
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
McDermott, M. T., & Kidd, G. S. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-377 · Cited by 96
Solbrig, C., Saucier-Sawyer, J. K., Cody, V., Saltzman, W. M., & Hanlon, D. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060107e · Cited by 94
Perlstein, I., Connolly, J. M., Cui, X. M., Song, C., Li, Q., Jones, P. L., Lu, Z., DeFelice, S., Klugherz, B. D., Wilensky, R. L., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302043 · Cited by 93
Chappell, J. C., Song, J. S., Burke, C. W., Klibanov, A. L., & Price, R. J. (2008) · Small · doi:10.1002/smll.200800806 · Cited by 93
Clawson, C., Huang, C.-T., Futalan, D., Seible, D. M., Saenz, R., Larsson, M., Ma, W., Minev, B., Zhang, Y., Ozkan, M., et al. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.03.001 · Cited by 87
Beaudette, T. T., Bachelder, E. M., Cohen, J. A., Obermeyer, A. C., Broaders, K. E., Fréchet, J. M. J., Kang, E.-S., Mende, I., Tseng, W. W., Davidson, M. G., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900038e · Cited by 79
Imbuluzqueta, E., Elizondo, E., Gamazo, C., Moreno‐Calvo, E., Veciana, J., Ventosa, N., & Blanco‐Prieto, M. J. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.031 · Cited by 78
Alternative Drug Delivery Approaches for the Therapy of Inflammatory Bowel Disease
Meißner, Y., & Lamprecht, A. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21216 · Cited by 78
van den Berg, J. H., Oosterhuis, K., Hennink, W. E., Storm, G., van der Aa, L. J., Engbersen, J. F. J., Haanen, J. B. A. G., Beijnen, J. H., Schumacher, T. N., & Nuijen, B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.005 · Cited by 77
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid
Bondioli, L., Costantino, L., Ballestrazzi, A., Lucchesi, D., Boraschi, D., Pellati, F., Benvenuti, S., Tosi, G., & Vandelli, M. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.049 · Cited by 75
Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis
Pillai, R. R., Somayaji, S. N., Rabinovich, M., Hudson, M. C., & Gonsalves, K. E. (2008) · Biomedical Materials · doi:10.1088/1748-6041/3/3/034114 · Cited by 72
The pharmaceutics and delivery of therapeutic polypeptides and proteins
Talmadge, J. E. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90049-a · Cited by 69
Nanoparticulate drug carriers based on hybrid poly(d,l-lactide-co-glycolide)-dendron structures
Costantino, L., Gandolfi, F., Bossy-Nobs, L., Tosi, G., Gurny, R., Rivasi, F., Vandelli, M. A., & Forni, F. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.026 · Cited by 68
Sun, S., Liang, N., Piao, H., et al. (2010) · Journal of Microencapsulation · doi:10.3109/02652040903515490 · Cited by 68
G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method
Choi, S. H., & Park, T. G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.023 · Cited by 66
Drug delivery in soft tissue engineering
Ladewig, K. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.588698 · Cited by 64
Tai, M. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00130-4 · Cited by 61
Conjugation of Bioactive Ligands to PEG-Grafted Chitosan at the Distal End of PEG
Fernández-Megía, E., Novoa-Carballal, R., Quiñoá, E., & Riguera, R. (2007) · Biomacromolecules · doi:10.1021/bm060889x · Cited by 60
Lecároz, M. C., Blanco‐Prieto, M. J., Campanero, M. A., Salman, H., & Gamazo, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00809-06 · Cited by 58
Surface functionalisation of PLGA nanoparticles for gene silencing
Andersen, M. Ø., Lichawska-Cieślar, A., Arpanaei, A., Jensen, S. M. R., Kaur, H., Oupický, D., Besenbacher, F., Kingshott, P., Kjems, J., & Howard, K. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.069 · Cited by 57
Rao, U. N. M., Lee, S. J., Luo, W., Mihm, M. C., & Kirkwood, J. M. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcptxmefovywda6 · Cited by 56
Release of DNA from dendriplexes encapsulated in PLGA nanoparticles
Ribeiro, S. J., Hussain, N., & Florence, A. T. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.036 · Cited by 54
Hanlon, D. J., Aldo, P. B., Devine, L., et al. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00968.x · Cited by 51
Molavi, O., Mahmud, A., Hamdy, S. I., Hung, R., Lai, R. L., Samuel, J., & Lavasanifar, A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900145g · Cited by 48
Drug delivery via the blood–brain barrier
Edwards, R. H. (2001) · Nature Neuroscience · doi:10.1038/85045 · Cited by 47
Garbayo, E., Ansorena, E., Lanciego, J. L., Blanco‐Prieto, M. J., & Aymerich, M. S. (2011) · Movement Disorders · doi:10.1002/mds.23793 · Cited by 47
Self-citationFernandez, É. M., Chang, J., Fontaine, J., Bialecki, E., Rodriguez, F., Werkmeister, E., Krieger, V., Ehret, C., Heurtault, B., Fournel, S., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.068 · Cited by 46
A Novel Technique for Loading of Paclitaxel-PLGA Nanoparticles onto ePTFE Vascular Grafts
Lim, H. J., Nam, H. Y., Lee, B. H., Kim, D. J., Ko, J. Y., & Park, J. (2007) · Biotechnology Progress · doi:10.1021/bp060338i · Cited by 46
Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles
Niu, X., Zou, W., Liu, C., Zhang, N., & Fu, C. (2009) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040902939221 · Cited by 44
Kumar, K. S., Ramakrishna, S., Saini, T. R., et al. (2006) · PubMed · Cited by 43
Scott, C. J., Marouf, W. M., Quinn, D. J., Buick, R. J., Orr, S. J., Donnelly, R. F., & McCarron, P. A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9400-7 · Cited by 43
Alshamsan, A., Hamdy, S. I., Haddadi, A., Samuel, J., El‐Kadi, A. O. S., Uludağ, H., & Lavasanifar, A. (2011) · Translational Oncology · doi:10.1593/tlo.11100 · Cited by 42
Pharmacological treatment of established rheumatoid arthritis
Lee, S. J.-A., & Kavanaugh, A. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00048-2 · Cited by 42
DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations
Joshi, M. D., Unger, W. W. J., van Beelen, A. J., Bruijns, S. C., Litjens, M., van Bloois, L., Kalay, H., van Kooyk, Y., & Storm, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.055 · Cited by 38
Foust, K. D., Flotte, T. R., Reier, P. J., & Mandel, R. J. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.104 · Cited by 38
Molecular aspects of vascular tissue engineering
Vorp, D. A. (2005) · Frontiers in bioscience · doi:10.2741/1571 · Cited by 36
Polymeric Nanoparticles for Sustained Down-Regulation of Annexin A2 Inhibit Prostate Tumor Growth
Braden, A., Kafka, M., Cunningham, L. S., Jones, H. P., & Vishwanatha, J. K. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.028 · Cited by 33
Nanoparticle-mediated p53 gene therapy for tumor inhibition
Sharma, B., Ma, W., Adjei, I. M., Panyam, J., Dimitrijevic, S., & Labhasetwar, V. D. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0008-9 · Cited by 31
Kumar, P. S., Saini, T. R., Durairaj, C., Yellepeddi, V., Sistla, R., & Diwan, P. V. (2007) · Drug Delivery · doi:10.1080/10717540701606467 · Cited by 31
Díez, S., Miguéliz, I., & de Ilarduya, C. T. (2009) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-009-0003-7 · Cited by 30
Molavi, O., Ma, Z., Hamdy, S. I., Lavasanifar, A., & Samuel, J. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802380452 · Cited by 21
Optimized Formulation of High-Payload PLGA Nanoparticles Containing Insulin–Lauryl Sulfate Complex
Shi, K., Cui, F., Yamamoto, H., & Kawashimà, Y. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802235894 · Cited by 21
Schmidt, C., Collnot, E. M., Bojarski, C., Schümann, M., Schulzke, J. D., Lehr, C. M., & Stallmach, A. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)63157-5 · Cited by 9
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cited by
Delivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging
Li, K., & Liu, B. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00014e · Cited by 987
A Review of Curcumin and Its Derivatives as Anticancer Agents
Tomeh, M. A., Hadianamrei, R., & Zhao, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051033 · Cited by 949
Metadata
- Authors
- Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 161
- Issue
- 2
- Pages
- 505-522
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2020398834
- Cited by
- 3,806
- References
- 200
- FWCI
- 66.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.